Large scale human trial of anti-AIDS gel in Africa
Main Category: HIV / AIDSArticle Date: 27 Mar 2004 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
British scientists are going to carry out large scale human trials on two gels that are designed to combat the AIDS virus. The trials will be carried out in Africa. If successful, tens of millions of people around the globe will soon be able to protect themselves from HIV with a simple and easy to apply dosage.
Currently, 60 gels are undergoing trials in 14 different studies around the world. The gels are known as microbicides.
According to Hilary Benn, UK International Development Secretary, women may be the ones with the most to gain from this.
Laboratory trials have been successful. Clinical tests will be carried out in South Africa, Zambia, Tanzania, Uganda and Cameroon. 12,000 women will be involved in the trial.
If all goes well, the gels could be on the market within the next six years (end of decade). 2.5 million lives may be saved in three years.
The microbicides could provide a barrier to the transmission of the HIV virus during sex. They were developed by the Medical Research Council and Imperial College, London (both UK). The UK government invested Ł17 in the research.
Even if the gels do work, it will still be an uphill struggle to bring the drugs within the price range of some of the poorest people in the world. Getting the drugs to people who need it the most will not be easy either.
The woman applies the gels (or creams) internally before sex. The gel stops the virus from entering her body.
Of the 40 million people in the world who are HIV positive, a large number got the virus because they were not able to protect themselves.
Many women in poorer countries find it hard to persuade their partners to wear a condom.
There are three ways the gels can work, by…
1. …..killing the virus before it enters the body.
2. …..preventing it from taking hold once inside the body.
3. …..creating a barrier to stop it from entering the body in the first place.
Visit our hiv / aids section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/6848.php>
APA
http://www.medicalnewstoday.com/releases/6848.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



